BRIEF published on 11/04/2025 at 07:35, 7 months 22 days ago MaaT Pharma Third Quarter 2025 Financial Results and Financing Update Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership
BRIEF published on 11/04/2025 at 07:35, 7 months 22 days ago MaaT Pharma : Résultats financiers et mise à jour du financement pour le troisième trimestre 2025 Résultats Financiers MaaT Pharma Agence Européenne Des Médicaments Xervyteg® Partenariat Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 7 months 22 days ago Inside Information / News release on accounts, results MaaT Pharma reports Q3 2025 financial results, secured financing, and partnership updates. Cash position of €22.4 million. Revenues increased by 45% year-over-year Revenues Financing Partnership MaaT Pharma Q3 2025
PRESS RELEASE published on 11/04/2025 at 07:30, 7 months 22 days ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma annonce ses activités de financement et résultats financiers T3 2025, incluant un accord avec Clinigen augmentant le CA de 45% Résultats Financiers Croissance Financement MaaT Pharma Accord Clinigen
BRIEF published on 10/13/2025 at 14:52, 8 months 12 days ago Franchissement de Seuils par Invus Public Equities dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Invus Public Equities
BRIEF published on 10/13/2025 at 14:52, 8 months 12 days ago Crossing of Thresholds by Invus Public Equities in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/13/2025 at 14:47, 8 months 12 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities pour MAAT PHARMA avec 4,96% du capital et des droits de vote suite à une cession d'actions sur le marché Franchissement De Seuils Marché Cession D'actions MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/07/2025 at 07:30, 8 months 19 days ago Informations privilégiées / Autres communiqués
BRIEF published on 10/06/2025 at 14:59, 8 months 19 days ago Symbiosis LLC réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Symbiosis LLC
BRIEF published on 10/06/2025 at 14:59, 8 months 19 days ago Symbiosis LLC Reduces Stake in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Symbiosis LLC
Published on 06/26/2026 at 01:40, 9 hours 23 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 11 hours 33 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 12 hours 33 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 13 hours 31 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 19 hours 33 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 10:50, 13 minutes ago Indotek Group acquires remaining 53% stake in Auchan Hungary, assumes full ownership
Published on 06/26/2026 at 10:47, 16 minutes ago flatexDEGIRO accelerates its growth trajectory and expects to achieve its 2027 financial targets already in 2026, one year ahead of schedule
Published on 06/26/2026 at 10:44, 19 minutes ago EQS-Adhoc: flatexDEGIRO SE: Full-year 2026 guidance raised, financial targets originally set for 2027 expected to be achieved already in 2026, one year ahead of time
Published on 06/26/2026 at 10:30, 33 minutes ago Uniper and Skyborn Renewables sign offshore wind PPA
Published on 06/26/2026 at 10:25, 38 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 06/26/2026 at 07:00, 4 hours 3 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 4 hours 3 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 16 hours 18 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 16 hours 33 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 17 hours 13 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
